Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
May 31, 2024 08:05 ET
|
Autonomix Medical, Inc.
Year marked by operational and clinical execution advancing the development of a potential breakthrough technology for the nervous system Continued progress in first study ever to evaluate...
Twin Disc, Inc. Completes Acquisition of Katsa Oy
May 31, 2024 08:00 ET
|
Twin Disc, Incorporated
MILWAUKEE, May 31, 2024 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ:TWIN) announced today that it has completed the previously announced acquisition of Katsa Oy (“Katsa”), a leading European...
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended December 31, 2023
May 31, 2024 08:00 ET
|
Haoxi Health Technology Limited
BEIJING, May 31, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today reported its...
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO
May 31, 2024 08:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL
Bionomics Limited Announces Private Placement of up to $70.0 Million
May 31, 2024 08:00 ET
|
Bionomics Ltd
ADELAIDE, Australia and CAMBRIDGE, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”), a clinical-stage biotechnology company developing novel,...
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 31, 2024 08:00 ET
|
Aptose Biosciences, Inc.
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Morphic to Participate in Jefferies Global Healthcare Conference
May 31, 2024 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious...
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
May 31, 2024 08:00 ET
|
PodcastOne
LOS ANGELES, May 31, 2024 (GLOBE NEWSWIRE) -- PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), announced today the appointment of Jon Merriman to its...
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
May 31, 2024 08:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., May 31, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in the Jefferies...
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
May 31, 2024 08:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus